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278Objective: There is growing consensus that the ascending aorta should be replaced at the time of aortic valve
replacement for bicuspid aortic valve even if it is only moderately dilated; the natural history of nonreplaced
sinuses of Valsalva is less clear.
Methods:We identified patients without defined connective tissue disorder undergoing primary aortic valve re-
placement for bicuspid aortic valve and separate repair of the ascending aorta without root replacement at the
Mayo Clinic between January 1, 1988, and December 31, 2007.
Results: Among 218 patients, 65 underwent ascending aortoplasty and 153 underwent separate graft replace-
ment of the ascending aorta. Of the latter group, 15 also had graft replacement of the noncoronary sinus. The
mean age at operation was 62  13 years. Valvular dysfunction was predominantly stenosis in 151 patients
(70%), regurgitation in 54 patients (25%), and mixed in 12 patients (5%). At a follow-up of up to 17 years (me-
dian, 3.3 years; range, 0–17 years), 10 patients (5%) had undergone late reoperation, of whom 1 had replacement
of the ascending aorta and 1 had replacement of the root for significant dilatation of the sinuses. Both patients
had originally undergone aortoplasty. No other patient required root surgery. One-, 5-, and 10-year freedom from
reoperation for any cause were 97.6%, 94.9%, and 85.5%, respectively.
Conclusions:Although progressive ascending aortic dilatation after aortic valve replacement for bicuspid aortic
valve is well documented, progressive dilatation of nonreplaced sinuses is not evident. Separate valve and graft
repair remains a reasonable surgical option in the setting of aortic valve replacement for bicuspid aortic valve
with ascending aortic dilatation provided the sinuses of Valsalva are not significantly enlarged. (J Thorac Car-
diovasc Surg 2011;142:278-84)Bicuspid aortic valve (BAV) is the most common congenital
valvular heart disease, affecting 0.9% to 2.0% of the gen-
eral population,1 and the underlying pathology responsible
for aortic valve replacement (AVR) in as many as one third
of patients in the United States.2 BAV is associated with
ascending aortic dilatation and enlargement of the aortic
valve annulus in as many as half of all individuals.3-8
Furthermore, ascending aortic dilatation may progress
even after successful AVR.9 Because ascending aortic dila-
tation is a widely recognized risk factor for aortic dissec-
tion,10 and patients with BAV are overrepresented in
autopsy series of aortic dissection,11 a more aggressive pos-
ture toward replacement of the moderately enlarged ascend-e Divisions of Cardiovascular Surgery,a Mayo Clinic, Rochester, Minn;
rtment of Thoracic and Cardiovascular Surgery,b St Paul’s Hospital, The
lic University of Korea, Seoul, Korea; and Divisions of Cardiovascular Med-
c Mayo Clinic, Rochester, Minn.
res: Authors have nothing to disclose with regard to commercial support.
nuscript was presented at the Aortic Symposium 2010, NewYork, New York,
29–30, 2010, as part of the POD (presentation on demand) portion of the
ng.
d for publication April 29, 2010; revisions received Aug 7, 2010; accepted for
ation Aug 29, 2010; available ahead of print Nov 1, 2010.
for reprints: Thoralf M. Sundt III, MD, Mayo Clinic, 200 1st St SW, Roches-
N, 55905 (E-mail: sundt.thoralf@mayo.edu).
Cardiovasc Surg 2011;142:278-84
23/$36.00
ht  2011 by The American Association for Thoracic Surgery
016/j.jtcvs.2010.08.055
The Journal of Thoracic and Cardiovascular Surging aorta has been advocated in the most recent American
College of Cardiology/American Heart Association guide-
lines for the treatment of valvular heart disease.12
Although progressive dilatation of the ascending seg-
ment is well documented, the risk of progressive dilatation
of the sinuses of Valsalva is less clear. The issue has prac-
tical significance because replacement of the sinuses either
as part of a composite root replacement or as a full valve-
sparing root mandates reimplantation of the coronary ar-
teries. Although these procedures are reported to carry
low operative risk by centers with large experience,13-15
data suggest that the risk is higher in the community at
large. In a study from the Society of Thoracic Surgeons
database, the incremental risk ratio associated with root
replacement relative to isolated AVR was 2.78.16 Compli-
cations related to coronary artery reimplantation occur,
even in experienced hands.17 The hazards of this approach
can be expected to be higher if a particularly aggressive
prophylactic approach is advocated in patients even when
the sinuses are not particularly enlarged because mobiliza-
tion and reimplantation of the nondisplaced coronary ostea
will be more difficult. Furthermore, if subsequent reopera-
tion is required either because a young patient opts for a bio-
prosthesis or a mechanical valve becomes infected or
obstructed by pannus, reoperative root replacement can be
expected to carry a higher risk than reoperative AVR.18ery c August 2011
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C
DThe alternative procedure to root replacement, a separate
valve and graft, obviates the risks associated with coronary
reimplantation but leaves the patient at potential risk of sub-
sequent sinus dilatation. A small series previously reported
suggested that late complications associated with separate
valve and graft were uncommon; however, follow-up was
limited.19 In the interest of further exploring this question
with a larger data set over a longer follow-up interval, we
examined our institutional experience with the late dilation
of nonreplaced sinuses of Valsalva after separate valve and
aortic repair in the setting of BAV disease.
MATERIALS AND METHODS
This study was approved by institutional review board of the Mayo
Clinic. All patients gave consent for inclusion in clinical research projects,
and study specific consent was waived. Patients with BAVundergoing pri-
mary separate AVR and repair of the ascending aorta by graft replacement
or aortoplasty between January 1, 1988, and December 31, 2007, were
identified via search of our prospectively managed, Society of Thoracic
Surgeons-compliant computerized clinical database. Patients with defined
connective tissue disorders (Marfan syndrome or Ehlers–Danlos syn-
drome) were excluded, as were thosewith concomitant procedures on other
valves. Perioperative data were collected from the database and retrospec-
tive review of medical records, including echocardiographic reports, pa-
thology reports, and all operative records. When possible, aortic root and
ascending aortic sizes were determined from preoperative and the most re-
cent echocardiograms. There is no uniform policy at the Mayo Clinic re-
garding size criteria for replacement of the sinuses, and it is therefore
likely that some mildly or even moderately enlarged sinuses were left in-
tact. In more recent years the approach has been more aggressive, including
replacement of the noncoronary sinus when enlarged with a tongue exten-
sion of graft material (Figure 1). Long-term follow-up information was
obtained by postal survey.
Statistical Analysis
Descriptive statistics were presented as mean  standard deviation for
continuous variables and frequency and percentage for categoric variables.
Preoperative and postoperative aortic root sizes were compared by paired t
test. Kaplan–Meier method was used to draw survival curves and calculate
5- and 10-year survival statistics and freedom from reoperation. Cox re-
gressionmodels were used to find the univariate andmultivariate predictors
of survival. Variables significant by univariate analysis (P<.05) were con-
sidered in the multivariable model, with model selection using the stepwise
method (backward and forward methods resulted in the same model). All
statistical tests were 2 sided with the alpha level set at 0.05 for statistical
significance. Analysis were performed using SAS (SAS Institute Inc,
Cary, NC).
RESULTS
The mean age at the time of surgery was 61.5 ( 13.0)
years (Table 1). Male patients predominated (75%). Of
note, 55% were smokers, 61% had hypertension, andThe Journal of Thoracic and Ca61% had hypercholesterolemia. Only 8 patients (3.7%)
had a history of aortic coarctation. The dominant functional
valvular disease was stenosis in 70% of patients and insuf-
ficiency in 25% of patients. The pattern of cusp fusion by
echocardiography or observation at the time of operation
was left and right cusp fusion in 132 patients (84%), right
and noncoronary cusp fusion in 24 patients (15%), and
left and noncoronary cusp fusion in 2 patients (1.3%).
Eighty-eight percent of patients had an identifiable raphe,
and 64% of patients had asymmetric cusps. Unfortunately,
data were not collected prospectively with regard to root
dimensions or phenotype.
Operative
As shown in Table 2, at surgery 153 patients underwent
graft replacement of the ascending aorta and 65 patients un-
derwent ascending aortoplasty. The choice between these
procedures, as was the choice between separate valve and
graft versus root replacement, was by the operating surgeon
and not by strict diameter criteria. There is no uniform insti-
tutional policy with regard to the procedure performed,
although aortoplasty is currently less common. Among pa-
tients with graft replacement of ascending aorta, the
noncoronary cusp was replaced or repaired in 15 patients
(6.9%) because of asymmetric enlargement. Concomitant
hemi-arch or total aortic arch replacement was performed
in 13 patients (6.0%). Mechanical and biological prostheses
were used in equal numbers. The mean age was 67  13
years for those receiving biological prostheses and 56 
10 years for those receiving a mechanical valve. During
this same time interval, 147 patients with BAV underwent
full root replacement.
Early Outcome
The operative mortality was 2.8% (6 patients). Fourteen
patients underwent reoperation for bleeding (6.6%). Post-
operative intraaortic balloon pump support was used in 8
patients (3.8%), and 19 patients required ventilation for
more than 24 hours (9.0%). Three patients (1.4%) had tran-
sient ischemic attacks, and 5 patients (2.4%)had permanent
stroke. Three patients had postoperative renal failure with
an increase of serum creatinine to greater than 2.0 mg/dL
or a doubling of the preoperative creatinine, or the institu-
tion of dialysis (1.4%). Two patients had postoperative
sepsis (0.9%).
Late Outcomes
The follow-upwas to amaximumof 17.2 years,with ame-
dian of 3.3 years. The completeness of follow-up by Clark’s
equation20 was 79%. During follow-up, 10 patients under-
went late reoperation for a variety of indications (Table 3).
There were no late reoperations for aortic root dissection
or rupture. A 67-year-old male patient who had undergone
AVR for aortic stenosis and reduction aortoplasty, as wellrdiovascular Surgery c Volume 142, Number 2 279
FIGURE 1. Freedom from late reoperation among patients with BAV dis-
ease undergoing separate AVR and repair of ascending aorta. CI, Confi-
dence interval.
TABLE 2. Operative characteristics
Variable Frequency*
ACC time (min) 68.8  28.9
CPB time (min) 96.0  43.7
Circulatory arrest time (min) 18.5  13.2
Operative procedures
NCC replace/plasty 6.9% (15)
Ascending aortoplasty 29.8% (65)
Ascending aorta graft replacement 70.2% (153)
Hemiarch replacement 5.0% (11)
Total arch replacement 0.9% (2)
Descending aorta replacement 0.5% (1)
Type of valve
Mechanical 50.0% (109)
Bioprosthetic 50.0% (109)
ACC, Aortic crossclamp; CPB, cardiopulmonary bypass; NCC; noncoronary cusp.
*Continuous variable was expressed as mean  standard deviation.
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Das coronary bypass, returned for graft replacement of the as-
cending aorta and root 9 years later for enlargement of the
ascending aorta to 63 mm. No computed tomography scan
is available from the time of his original operation, nor are
there recorded measurements of his root at surgery. His op-
erative note mentions only dilatation of the ascending aorta.
At reoperation both the ascending aorta and root were en-
larged. The ascending aorta and root were replaced with
a Dacron tube graft sewn to thewell-functioning aortic pros-
thesis. A second patient underwent graft replacement of the
ascending aorta after prior aortoplasty. Overall, as shown in
Figure 1, freedom from late reoperation was 97.6%, 94.9%,
and 85.5% at 1, 5, and 10 years, respectively.TABLE 1. Preoperative patient characteristics
Variable Frequency*
Age (y) 61.5  13.0
Sex (male) 75.2% (164)
Smoke 55.0% (120)
Diabetes mellitus 10.1% (22)
Hypercholesterolemia 60.6% (131)
Preoperative renal failure 2.3% (5)
Hypertension 60.6% (131)
Cerebrovascular accident 2.3% (5)
Peripheral vascular disease 9.3% (20)
NYHA (III/IV) 39.0% (82)
Coronary artery disease 30.7% (67)
History of coarctation of aorta 3.7% (8)
Previous CABG 4.6% (10)
Dominance of AV disease
Aortic stenosis 69.6% (151)
Aortic insufficiency 24.9% (54)
Mixed 5.5% (12)
EF (%) 59.5  11.7
NYHA, New York Heart Association; CABG, coronary artery bypass graft; AV, aortic
valve; EF, ejection fraction. *Continuous variable was expressed as mean  standard
deviation.
280 The Journal of Thoracic and Cardiovascular SurgA total of 28 patients (12.8%) died during follow-up, in
whom the cause was known to be cardiac in 5 (17.9%) and
noncardiac in 11 (39.3%). Causes of death were unknown
in 12 patients (42.9%). The overall survivals for all patients
were 95.8%, 89.4%, and 79.0% at 1, 5, 10 years, respec-
tively (Figure 2). Predictors of overall survival by multivar-
iate analysis were age (hazard ratio [HR], 1.07; P ¼ .001),
diabetes mellitus (HR, 5.32; P<.001), preoperative renal
failure (HR, 8.43; P ¼ .001), and New York Heart Associ-
ation III/IV (HR, 2.28; P¼ .04), as shown in Table 4. Use of
a bioprosthetic valve at the initial operation appeared in uni-
variate but not multivariate analysis, likely because biopros-
thetic valves were used in older patients.
Paired echocardiograms preoperatively and at least 3
months postoperatively with adequate measurements of
the sinus diameter were available for 34 patients at
a mean of 5.0  4.2 years. Of these, 6 had replacement of
their noncoronary sinus. As shown in Figure 3, among those
patients without a noncoronary sinus procedure (n ¼ 28),
the measured diameter of sinuses of Valsalva decreased
slightly from a mean of 42.0  5.3 mm preoperatively to
40.1 5.1 mm postoperatively (P¼ .006). When expressed
as change in diameter versus time as shown in Figure 4, no
relationship is apparent. As expected, the diameter of the
aortic annulus did not differ between preoperative and post-
operative echocardiographic studies (mean, 24.7  3.1 mm
vs 23.8  1.9 mm; P ¼ .39); however, the diameter of the
sinotubular junction (mean, 34.6  8.4 mm vs 31.6  9.7
mm; P ¼ .02) and the ascending aorta (50.0  6.7 mm vs
36.8 6.8 mm; P<.001) were significantly decreased after
operation.DISCUSSION
The results of this study indicate that although enlarge-
ment of the ascending aorta after AVR for BAV occurs
with sufficient frequency to be clinically apparent,ery c August 2011
TABLE 3. Details for reoperations
Age, y Gender Interval (y) Primary operation Reason for reoperation Title of reoperation
75 M 0.9 AVRþAscAo replacement Mediastinitis AscAo replacement with valveless homograft
75 M 0.3 AVRþAscAo replacement PVE Homograft replacement of aortic root
71 M 0.3 AVRþAscAo replacement PVE AVR
67 M 9.2 AVRþaortoplastyþCABG Dilatation of aortic root
and AscAo
Graft replacement of aortic root and
AscAo
65 M 3.8 AVRþaortoplasty PVE Homograft replacement of aortic root and
CABG
65 M 1.5 AVRþaortoplasty RCA aneurysm CABG
63 M 1.3 AVRþAscAo replacementþ
PFO closure
Periprosthetic leakage Repair of periprosthetic leakage
60 M 0.1 AVRþ total archþproximal descending
aorta replacementþCABG
Thoracoabdominal aneurysm Replacement of thoracoabdominal aorta
49 M 13.2 AVRþaortoplasty PPM AVRþCABG
40 M 9.0 AVRþaortoplasty PPM and AscAo dilatation AVRþAscAo replacement
AVR, Aortic valve replacement; PPM, patient–prosthesis mismatch; CABG, coronary artery bypass grafting; AscAo, ascending aorta; RCA, right coronary artery; PVE, prosthetic
valve endocarditis; PFO, patent foramen ovale.
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Dprogressive enlargement of the sinuses of Valsalva seems to
be uncommon. Among the study population reported in this
article, with a follow-up period of up to 17 years, there were
no known instances of root rupture or dissection, and no ev-
idence of progressive sinus enlargement by echocardiogra-
phy in the subset with serial examinations. Of 218 patients
in the study, only 2 underwent reoperation for replacement
of the ascending aorta, 1 of whom had root replacement at
the reoperation; both had undergone ascending aortoplasty,
not graft replacement, at the original operation. These data
suggest that, in clinical practice, those sinuses thought by an
operating surgeon at the time of AVR not to be sufficiently
enlarged to justify formal root replacement seldom lead to
reoperation. Therefore, although prophylactic replacement
of the moderately ascending aorta is strongly recommended
at the time of AVR, a more circumspect posture toward rou-
tine aortic root replacement is appropriate. Composite root
replacement is a well-established procedure; however, it isFIGURE 2. Overall survival in patients with BAV disease undergoing sep-
arate AVR and repair of ascending aorta and the survival of an age- and
gender-matched Minnesota population. CI, Confidence interval.
The Journal of Thoracic and Catechnically more challenging and carries risks of coronary
osteal complications, including bleeding, kinking, and false
aneurysm formation.21 Given the frequency of AVR for
BAV, any unnecessary incremental increase in risk applied
globally will have a powerful clinical impact. Therefore, al-
though clearly dilated sinuses of Valsalva should not be left
unaddressed, a separate valve and graft remains an appro-
priate procedure for some patients with BAVand ascending
aortic dilatation without significant root enlargement.19
The findings of this study are consistent with an earlier,
smaller study from another institution that also showed
a place for separate valve and graft alongside root replace-
ment as options in the management of BAV disease associ-
ated with aortopathy.19 We believe that this is because the
aortopathy associated with BAVis phenotypically heteroge-
neous, with some aneurysms appearing to be entirely supra-
coronary and others involving the root much as one may see
in Marfan syndrome (Figure 4). An intermediate phenotype
is also observed with effacement of the sinotubular junction
and generalized enlargement of both the ascending aorta
and root, as well as proximal arch in many cases. Much
of the existing literature fails to account for this heterogene-
ity, focusing on mean aortic diameters rather than identify-
ing subsets. There is also room for confusion given loose
application in the literature of segmental anatomic termi-
nology for pathology of the root versus the ascending aorta.
A conservative view of replacement of the sinuses is also
supported by literature demonstrating a somewhat slower
rate of enlargement of the sinuses of Valsalva of between
0.03 and 0.91 (mm/y) compared with the ascending aorta
at 0.18 to 1.18 (mm/y), perhaps because of different hemo-
dynamic stresses.9,22-26 Furthermore, although an argument
for prophylactic repair of the ascending aorta may be made
based on the concept of a generalized aortopathy,27 clinical
experience indicates that the aortopathy in BAV disease is
segmental. For example, involvement of the descendingrdiovascular Surgery c Volume 142, Number 2 281
TABLE 4. Univariate and multivariate analyses for overall survival
Univariate Multivariate
HR CI P value HR CI P value
Age 1.08 0.03–1.12 .001 1.07 1.03–1.12 .001
DM 4.99 2.06–12.07 <.001 5.32 2.12–13.3 <.001
Preoperative RF 6.86 2.02–23.3 .002 8.43 2.36–30.1 .001
NYHA (III/IV) 2.41 1.1–5.27 .028 2.28 1.02–5.1 .044
CAD 3.62 1.7–7.71 <.001
Bioprosthetic valve 2.47 1.13–5.4 .023
HR, Hazard ratio; CI, confidence interval; DM, diabetes mellitus; RF, renal failure; NYHA, New York Heart Association; CAD, coronary artery disease; EF, ejection fraction.
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Dthoracic aorta is uncommon in the absence of coarctation
and, whereas Stanford type A dissections appear 10-fold
over-represented among patients with BAV, type B dissec-
tion is not.11
Our data may be taken to be at variance with those of
others, who have recommended full root replacement in pa-
tients with BAV with aortic valve dysfunction and com-
bined ascending aortic dilatation more than 4 to 4.5 cm.28
Russo and colleagues29 reported 6% aortic reoperation af-
ter AVR in patients with BAV during 20 years; on closer in-
spection, however, there were no reoperations for pathology
of aortic root. Borger and colleagues30 reported an 11% in-
cidence of ascending aortic complications during 10 years
of follow-up after AVR for BAV, including 19 patients un-
dergoing replacement of ascending aorta, 18 patients devel-
oping aortic aneurysms, and 1 patient experiencing aortic
dissection. They reported no cases of aortic root pathology.
Furthermore, in an older report of patients with aneurysms
of diverse cause in which the long-term results of separate
valve and graft were compared with composite replace-
ment, the Stanford group reported 49 of 255 patients under-
going separate valve and ascending aortic repair coming to
late reoperation, of which 35 of the reoperations were on the
valve itself and 7 were for aneurysmal dilatation of the si-
nuses of Valsalva. Of these 7 patients, 5 had acute or chronic
dissection and 4 had Marfan syndrome.31 Similarly, in
the Baylor experience of 277 patients undergoing root--25.0
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282 The Journal of Thoracic and Cardiovascular Surgsparing techniques between 1953 and 1992 among 210
operative survivors with long-term follow-up, aortic root
aneurysms developed in 9, of whom 8 had Marfan syn-
drome.32 The data to support routine replacement of the si-
nuses in BAV disease absent Marfan syndrome are,
therefore, scant.
A number of patients in our series underwent aortoplasty.
The majority of these patients had surgery early in the se-
ries. Over time, we have shifted largely away from aorto-
plasty in favor of graft replacement as more hemostatic
grafts diminish the advantage of aortoplasty. Remarkably,
of these 65 patients, only 2 have undergone reoperation.
We do not, however, advocate this approach as a matter of
routine and it is reserved currently for only a small subset
of patients in whom the enlargement is mild at most.
The overall survival of patients in our series at 5 and 10
years was 89% and 79%, respectively, and was compara-
ble to that of age- and gender-matched controls. This is su-
perior to that reported by Sioris and colleagues,33 who
reported a 10-year survival of only 57% for patients under-
going supracoronary replacement of ascending aorta com-
pared with 74% for patients undergoing the Bentall
operation. In their series, however, patients undergoing
composite root replacement were younger and less often
had concomitant coronary artery disease, as was the case
in the Washington University expereince.19 Survival in
the series from Stanford was also lower than that in ours,10.0 12.0 14.0 16.0 18.0
 interval
erial echocardiography versus time in years.
ery c August 2011
FIGURE 4. In our experience, there are 3 commonly observed phenotypes of aneurysm associated with BAV disease: The most common is supracoronary
enlargement with preservation of the sinotubular junction (type 1). The next most common demonstrates ectasia of the ascending aorta and root with ef-
facement of the sinotubular junction (type 2). The least common is strikingly similar in appearance to the aneurysm typical of Marfan syndrome and is
confined to the root itself (type 3).
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Dwith 1-, 5-, and 10-year survival after separate graft and
valve replacement of 78%, 67%, and 51%, respectively,
compared with 85%, 80%, and 68%, respectively, after
composite root replacement.31 Again, in contrast with our
series, however, they included patients with aneurysms of
various causes. Both sets of authors concluded that there
remains a place for a separate supracoronary graft and
valve operations in addition to root replacement. The
long-term survival in our series suggests that our surgical
treatment policy is appropriate and does not reduce the
life expectancy in patients with BAV.
Study Limitations
The principle limitations of our study are a lack of quan-
titative data concerning the actual sinus dimensions at the
time of surgery and incomplete imaging follow-up of theThe Journal of Thoracic and Casinus dimensions. In addition, although the maximum
follow-up is to 17 years, the mean follow-up is considerably
shorter at 3.3 years, placing obvious constraints on our abil-
ity to predict with certainty the likelihood of root dilatation
over a prolonged period of time. Still, this is a relatively
large series of patients with follow-up exceeding 8 years
in 50 patients, and we believe the data are clinically useful.
The tendency at the Mayo Clinic is to be less aggressive in
root replacement than other surgeons have reported, as re-
flected by the comparable frequency with which separate
valve and graft replacements and formal root replacement
were performed. Accordingly, our long-term results should
represent a ‘‘worst case scenario’’ in terms of the risk of di-
latation. Conversely, the lack of follow-up imaging data
weakens arguments regarding the actual rate of subsequent
enlargement, because the incidence of clinically silent rootrdiovascular Surgery c Volume 142, Number 2 283
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Ddilatation is unknown. Still, in the end, the most clinically
relevant end point for the patient is survival, and our
survival data suggest that patients are not experiencing ill
consequences from this perspective.
CONCLUSIONS
Absent quantitative data and a sufficient event rate, we
cannot establish an evidence-based threshold number below
which the sinuses may be left. It is our general practice,
however, to routinely replace the root when it exceeds 5
cm diameter or the coronary ostia are displaced more than
2 cm from the surgical annulus, and to leave the root intact
when it is less than 4.5 cm in diameter or the ostia are not
displaced. When the root diameter falls between these pa-
rameters, we are influenced by the age of the patient, being
more aggressive in younger patients who will be at risk for
progressive dilatation for a longer period of time and in
whom mobilization of less displaced coronary arteries is
likely to be easier. We are also influenced by the general
phenotype of the root, being more likely to leave the root in-
tact if the sinotubular junction is intact (‘‘type I’’) and more
inclined to replace if effaced (type II or III).
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